Analysis of Factors Determining Patient Survival after Receiving Free-Flap Reconstruction at a Single Center—A Retrospective Cohort Study
Open Access
- 21 November 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (11) , 2877
Abstract
Background: Microsurgical tissue transfer revolutionized reconstructive surgery after extensive trauma, oncological resections, and severe infections. Complex soft tissue reconstructions are increasingly performed in multimorbid and elderly patients. Therefore, it is crucial to investigate whether these patients benefit from these complex procedures. Objective: To evaluate the outcome for multimorbid patients who underwent microsurgical soft tissue reconstruction and to identify potential risk factors that may increase mortality. Methods: This single-center study retrospectively analyzed prospectively collected data of patients receiving free gracilis (GM) or latissimus dorsi muscle (LDM) flap reconstruction between September 2017 and December 2021. Cases were divided into two groups (dead vs. alive), depending on patient survival. Patient demographics, comorbidities and medication, perioperative details, free flap outcome, as well as microcirculation were determined. Results: A total of 151 flaps (LDM, n = 67; GM, n = 84) performed in 147 patients with a mean age of 61.15 ± 17.5 (range 19–94) years were included. A total of 33 patients (22.45%) passed away during the study period. Deceased patients were significantly older (Alive: 58.28 ± 17.91 vs. Dead: 71.39 ± 11.13; p = 0.001), were hospitalized significantly longer (Alive: 29.66 ± 26.97 vs. Dead: 36.88 ± 15.04 days; p = 0.046) and suffered from cardiovascular (Alive: 36.40% vs. Dead: 66.70%; p = 0.002) and metabolic diseases (Alive: 33.90% vs. Dead: 54.50%; p = 0.031) more frequently, which corresponded to a significantly higher ASA Score (p = 0.004). Revision rates (Alive: 11.00% vs. Dead: 18.20%; p = 0.371) and flap loss (Alive: 3.39% vs. Dead: 12.12%; p = 0.069) were higher in patients that died by the end of the study period. Conclusions: Free flap transfer is safe and effective, even in multimorbid patients. However, patient age, comorbidities, preoperative ASA status, and medication significantly impact postoperative patient survival in the short- and mid-term and must, therefore, be taken into account in preoperative decision-making and informed consent.Keywords
This publication has 40 references indexed in Scilit:
- Analysis of risk factors for flap loss and salvage in free flap head and neck reconstructionHead & Neck, 2015
- Force Recovery Assessment of Functioning Free Muscle Transfers Using UltrasonographyThe Journal of Hand Surgery, 2014
- Diabetic foot reconstruction using free flaps increases 5-year-survival rateJournal of Plastic, Reconstructive & Aesthetic Surgery, 2013
- Free flap microcirculatory monitoring correlates to free flap temperature assessmentJournal of Plastic, Reconstructive & Aesthetic Surgery, 2011
- Quadriceps muscle reconstruction with free functioning latissimus dorsi muscle flap after oncological resectionMicrosurgery, 2008
- Die alternative autologe Brustrekonstruktion mit dem queren GrazilislappenHandchirurgie · Mikrochirurgie · Plastische Chirurgie, 2008
- Breast Reconstruction with Free Flaps from the Abdominal Donor Site—TRAM, DIEAP, and SIEA FlapsClinics in Plastic Surgery, 2007
- Limb-salvage by Femoro-distal Bypass and Free Muscle Flap TransferEuropean Journal of Vascular and Endovascular Surgery, 2004
- The Gracilis Free Muscle Flap is More than Just a “Graceful” Flap for Lower-Leg ReconstructionJournal of Reconstructive Microsurgery, 2004
- DISTANT TRANSFER OF AN ISLAND FLAP BY MICROVASCULAR ANASTOMOSESPlastic and Reconstructive Surgery, 1973